ArticleNaunyn-Schmiedeberg's archives of pharmacology2009

Safety of the novel atrial-selective K+-channel blocker AVE0118 in experimental heart failure.

H-J Schneider et al.PubMed ↗Publisher ↗

No numbers read from the abstract.